GTS5:Autoimmune lymphoproliferative syndrome (FAS): Difference between revisions
| [checked revision] | [checked revision] |
Bailey.Glen (talk | contribs) No edit summary |
Bailey.Glen (talk | contribs) No edit summary |
||
| Line 27: | Line 27: | ||
==Related Terminology== | ==Related Terminology== | ||
{| class="wikitable" | {| class="wikitable" | ||
|+ | |+ | ||
|Acceptable | |Acceptable | ||
| | |N/A | ||
|- | |- | ||
|Not Recommended | |Not Recommended | ||
| | |Canale-Smith syndrome; Dianzani autoimmune lymphoproliferative disease; CD95R deficiency; CD95L deficiency | ||
|} | |} | ||